ID   T23O_HUMAN              Reviewed;         406 AA.
AC   P48775; A8K053;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Tryptophan 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020};
DE            Short=TDO {ECO:0000255|HAMAP-Rule:MF_03020};
DE            EC=1.13.11.11 {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317};
DE   AltName: Full=Tryptamin 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020};
DE   AltName: Full=Tryptophan oxygenase {ECO:0000255|HAMAP-Rule:MF_03020};
DE            Short=TO {ECO:0000255|HAMAP-Rule:MF_03020};
DE            Short=TRPO {ECO:0000255|HAMAP-Rule:MF_03020};
DE   AltName: Full=Tryptophan pyrrolase {ECO:0000255|HAMAP-Rule:MF_03020};
DE   AltName: Full=Tryptophanase {ECO:0000255|HAMAP-Rule:MF_03020};
GN   Name=TDO2 {ECO:0000255|HAMAP-Rule:MF_03020}; Synonyms=TDO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8666386; DOI=10.1006/geno.1995.9990;
RA   Comings D.E., Muhleman D., Dietz G., Sherman M., Forest G.L.;
RT   "Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a
RT   glucocorticoid response-like element composed of a GTT repeat and an
RT   intronic CCCCT repeat.";
RL   Genomics 29:390-396(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000244|PDB:4PW8}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 19-388 OF APOPROTEIN,
RP   SUBUNIT, CATALYTIC ACTIVITY, FUNCTION, COFACTOR, PATHWAY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF TYR-42; TYR-45;
RP   PHE-72; HIS-76; PHE-140; ARG-144; SER-151 AND HIS-328.
RX   PubMed=25066423; DOI=10.1002/prot.24653;
RA   Meng B., Wu D., Gu J., Ouyang S., Ding W., Liu Z.J.;
RT   "Structural and functional analyses of human tryptophan 2,3-
RT   dioxygenase.";
RL   Proteins 82:3210-3216(2014).
RN   [6] {ECO:0000244|PDB:5TI9, ECO:0000244|PDB:5TIA}
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 18-389 IN COMPLEX WITH HEME
RP   AND TRYPTOPHAN, COFACTOR, SUBUNIT, CATALYTIC ACTIVITY, PATHWAY, AND
RP   MUTAGENESIS OF TYR-175.
RX   PubMed=27762317; DOI=10.1038/srep35169;
RA   Lewis-Ballester A., Forouhar F., Kim S.M., Lew S., Wang Y.,
RA   Karkashon S., Seetharaman J., Batabyal D., Chiang B.Y., Hussain M.,
RA   Correia M.A., Yeh S.R., Tong L.;
RT   "Molecular basis for catalysis and substrate-mediated cellular
RT   stabilization of human tryptophan 2,3-dioxygenase.";
RL   Sci. Rep. 6:35169-35169(2016).
CC   -!- FUNCTION: Heme-dependent dioxygenase that catalyzes the oxidative
CC       cleavage of the L-tryptophan (L-Trp) pyrrole ring and converts L-
CC       tryptophan to N-formyl-L-kynurenine. Catalyzes the oxidative
CC       cleavage of the indole moiety. {ECO:0000255|HAMAP-Rule:MF_03020,
CC       ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317}.
CC   -!- CATALYTIC ACTIVITY: L-tryptophan + O(2) = N-formyl-L-kynurenine.
CC       {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423,
CC       ECO:0000269|PubMed:27762317}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03020,
CC         ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317};
CC       Note=Binds 1 heme group per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_03020, ECO:0000269|PubMed:27762317};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.135 mM for L-tryptophan {ECO:0000269|PubMed:25066423};
CC   -!- PATHWAY: Amino-acid degradation; L-tryptophan degradation via
CC       kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.
CC       {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423,
CC       ECO:0000269|PubMed:27762317}.
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. {ECO:0000255|HAMAP-
CC       Rule:MF_03020, ECO:0000269|PubMed:25066423,
CC       ECO:0000269|PubMed:27762317}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-743494, EBI-743494;
CC       O95671:ASMTL; NbExp=8; IntAct=EBI-743494, EBI-743231;
CC       O60762:DPM1; NbExp=6; IntAct=EBI-743494, EBI-719526;
CC       P06730:EIF4E; NbExp=3; IntAct=EBI-743494, EBI-73440;
CC       Q9H8S9:MOB1A; NbExp=5; IntAct=EBI-743494, EBI-748229;
CC       Q70IA8:MOB3C; NbExp=3; IntAct=EBI-743494, EBI-9679267;
CC       Q9NPG2:NGB; NbExp=5; IntAct=EBI-743494, EBI-10311409;
CC       Q9NRD5:PICK1; NbExp=4; IntAct=EBI-743494, EBI-79165;
CC       Q8IYS1:PM20D2; NbExp=4; IntAct=EBI-743494, EBI-11339910;
CC       O00560:SDCBP; NbExp=7; IntAct=EBI-743494, EBI-727004;
CC       Q9H190:SDCBP2; NbExp=3; IntAct=EBI-743494, EBI-742426;
CC       Q96H43:ZFYVE26; NbExp=5; IntAct=EBI-743494, EBI-10286915;
CC   -!- SIMILARITY: Belongs to the tryptophan 2,3-dioxygenase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03020}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U32989; AAB08514.1; -; mRNA.
DR   EMBL; AK289418; BAF82107.1; -; mRNA.
DR   EMBL; CH471056; EAX04885.1; -; Genomic_DNA.
DR   EMBL; BC005355; AAH05355.1; -; mRNA.
DR   CCDS; CCDS34086.1; -.
DR   PIR; G02022; G02022.
DR   RefSeq; NP_005642.1; NM_005651.3.
DR   UniGene; Hs.183671; -.
DR   UniGene; Hs.593955; -.
DR   PDB; 4PW8; X-ray; 2.90 A; A/B/C/D/E/F/G/H=19-388.
DR   PDB; 5TI9; X-ray; 2.50 A; A/B/C/D=18-389.
DR   PDB; 5TIA; X-ray; 2.44 A; A/B/C/D=18-389.
DR   PDBsum; 4PW8; -.
DR   PDBsum; 5TI9; -.
DR   PDBsum; 5TIA; -.
DR   ProteinModelPortal; P48775; -.
DR   SMR; P48775; -.
DR   BioGrid; 112858; 16.
DR   IntAct; P48775; 18.
DR   MINT; MINT-1446261; -.
DR   STRING; 9606.ENSP00000444788; -.
DR   BindingDB; P48775; -.
DR   ChEMBL; CHEMBL2140; -.
DR   DrugBank; DB00150; L-Tryptophan.
DR   DrugBank; DB00779; Nalidixic Acid.
DR   DrugBank; DB00500; Tolmetin.
DR   GuidetoPHARMACOLOGY; 2887; -.
DR   iPTMnet; P48775; -.
DR   PhosphoSitePlus; P48775; -.
DR   BioMuta; TDO2; -.
DR   DMDM; 1351188; -.
DR   PaxDb; P48775; -.
DR   PeptideAtlas; P48775; -.
DR   PRIDE; P48775; -.
DR   DNASU; 6999; -.
DR   Ensembl; ENST00000536354; ENSP00000444788; ENSG00000151790.
DR   Ensembl; ENST00000573403; ENSP00000460086; ENSG00000262635.
DR   GeneID; 6999; -.
DR   KEGG; hsa:6999; -.
DR   UCSC; uc003ipf.3; human.
DR   CTD; 6999; -.
DR   DisGeNET; 6999; -.
DR   GeneCards; TDO2; -.
DR   HGNC; HGNC:11708; TDO2.
DR   HPA; HPA039611; -.
DR   MalaCards; TDO2; -.
DR   MIM; 191070; gene.
DR   neXtProt; NX_P48775; -.
DR   OpenTargets; ENSG00000151790; -.
DR   PharmGKB; PA36427; -.
DR   eggNOG; KOG3906; Eukaryota.
DR   eggNOG; COG3483; LUCA.
DR   GeneTree; ENSGT00390000008593; -.
DR   HOGENOM; HOG000221584; -.
DR   HOVERGEN; HBG003043; -.
DR   InParanoid; P48775; -.
DR   KO; K00453; -.
DR   OMA; WRYNHVL; -.
DR   OrthoDB; EOG091G080K; -.
DR   PhylomeDB; P48775; -.
DR   TreeFam; TF105827; -.
DR   BioCyc; MetaCyc:HS07771-MONOMER; -.
DR   BRENDA; 1.13.11.11; 2681.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   UniPathway; UPA00333; UER00453.
DR   ChiTaRS; TDO2; human.
DR   GeneWiki; TDO2; -.
DR   GenomeRNAi; 6999; -.
DR   PRO; PR:P48775; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000151790; -.
DR   CleanEx; HS_TDO2; -.
DR   ExpressionAtlas; P48775; baseline and differential.
DR   Genevisible; P48775; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019825; F:oxygen binding; IEA:Ensembl.
DR   GO; GO:0004833; F:tryptophan 2,3-dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0006569; P:tryptophan catabolic process; TAS:Reactome.
DR   GO; GO:0019442; P:tryptophan catabolic process to acetyl-CoA; IBA:GO_Central.
DR   GO; GO:0019441; P:tryptophan catabolic process to kynurenine; IDA:UniProtKB.
DR   HAMAP; MF_01972; T23O; 1.
DR   InterPro; IPR004981; Trp_2_3_dOase.
DR   PANTHER; PTHR10138; PTHR10138; 1.
DR   Pfam; PF03301; Trp_dioxygenase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Dioxygenase; Heme; Iron;
KW   Metal-binding; Oxidoreductase; Reference proteome;
KW   Tryptophan catabolism.
FT   CHAIN         1    406       Tryptophan 2,3-dioxygenase.
FT                                /FTId=PRO_0000072399.
FT   REGION       72     76       Substrate binding. {ECO:0000244|PDB:5TI9,
FT                                ECO:0000255|HAMAP-Rule:MF_03020,
FT                                ECO:0000269|PubMed:27762317}.
FT   METAL       328    328       Iron (heme axial ligand).
FT                                {ECO:0000244|PDB:5TI9, ECO:0000255|HAMAP-
FT                                Rule:MF_03020,
FT                                ECO:0000269|PubMed:27762317}.
FT   BINDING     144    144       Substrate. {ECO:0000244|PDB:5TI9,
FT                                ECO:0000255|HAMAP-Rule:MF_03020,
FT                                ECO:0000269|PubMed:27762317}.
FT   BINDING     342    342       Substrate. {ECO:0000244|PDB:5TI9,
FT                                ECO:0000255|HAMAP-Rule:MF_03020,
FT                                ECO:0000269|PubMed:27762317}.
FT   MUTAGEN      42     42       Y->A: Reduces enzyme activity by 99%.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN      45     45       Y->A: Reduces enzyme activity by 99%.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN      72     72       F->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN      76     76       H->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN     140    140       F->A: Reduces enzyme activity by 99%.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN     144    144       R->A: Reduces enzyme activity by 99%.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN     151    151       S->A: Reduces enzyme activity by 90%.
FT                                {ECO:0000269|PubMed:25066423}.
FT   MUTAGEN     175    175       Y->G: Reduces enzyme activity.
FT                                {ECO:0000269|PubMed:27762317}.
FT   MUTAGEN     328    328       H->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25066423}.
FT   HELIX        42     45       {ECO:0000244|PDB:5TIA}.
FT   HELIX        48     51       {ECO:0000244|PDB:5TIA}.
FT   HELIX        58     61       {ECO:0000244|PDB:5TIA}.
FT   HELIX        68     98       {ECO:0000244|PDB:5TIA}.
FT   HELIX       101    103       {ECO:0000244|PDB:5TIA}.
FT   HELIX       105    107       {ECO:0000244|PDB:5TIA}.
FT   HELIX       108    127       {ECO:0000244|PDB:5TIA}.
FT   HELIX       129    132       {ECO:0000244|PDB:5TIA}.
FT   HELIX       137    140       {ECO:0000244|PDB:5TIA}.
FT   TURN        141    143       {ECO:0000244|PDB:5TIA}.
FT   HELIX       144    146       {ECO:0000244|PDB:5TIA}.
FT   TURN        147    149       {ECO:0000244|PDB:5TIA}.
FT   HELIX       152    154       {ECO:0000244|PDB:5TIA}.
FT   HELIX       156    165       {ECO:0000244|PDB:5TIA}.
FT   TURN        169    171       {ECO:0000244|PDB:5TIA}.
FT   HELIX       174    177       {ECO:0000244|PDB:5TIA}.
FT   HELIX       186    197       {ECO:0000244|PDB:5TIA}.
FT   HELIX       201    210       {ECO:0000244|PDB:5TIA}.
FT   TURN        217    220       {ECO:0000244|PDB:5TIA}.
FT   HELIX       222    243       {ECO:0000244|PDB:5TIA}.
FT   STRAND      246    248       {ECO:0000244|PDB:4PW8}.
FT   HELIX       252    266       {ECO:0000244|PDB:5TIA}.
FT   HELIX       270    276       {ECO:0000244|PDB:5TIA}.
FT   TURN        277    280       {ECO:0000244|PDB:5TIA}.
FT   HELIX       286    297       {ECO:0000244|PDB:5TIA}.
FT   TURN        298    300       {ECO:0000244|PDB:5TIA}.
FT   HELIX       302    336       {ECO:0000244|PDB:5TIA}.
FT   HELIX       348    352       {ECO:0000244|PDB:5TIA}.
FT   HELIX       357    359       {ECO:0000244|PDB:5TIA}.
FT   HELIX       363    367       {ECO:0000244|PDB:5TIA}.
FT   HELIX       368    371       {ECO:0000244|PDB:5TIA}.
FT   HELIX       375    377       {ECO:0000244|PDB:5TIA}.
FT   HELIX       383    388       {ECO:0000244|PDB:5TIA}.
SQ   SEQUENCE   406 AA;  47872 MW;  1B89901F445B79FE CRC64;
     MSGCPFLGNN FGYTFKKLPV EGSEEDKSQT GVNRASKGGL IYGNYLHLEK VLNAQELQSE
     TKGNKIHDEH LFIITHQAYE LWFKQILWEL DSVREIFQNG HVRDERNMLK VVSRMHRVSV
     ILKLLVQQFS ILETMTALDF NDFREYLSPA SGFQSLQFRL LENKIGVLQN MRVPYNRRHY
     RDNFKGEENE LLLKSEQEKT LLELVEAWLE RTPGLEPHGF NFWGKLEKNI TRGLEEEFIR
     IQAKEESEEK EEQVAEFQKQ KEVLLSLFDE KRHEHLLSKG ERRLSYRALQ GALMIYFYRE
     EPRFQVPFQL LTSLMDIDSL MTKWRYNHVC MVHRMLGSKA GTGGSSGYHY LRSTVSDRYK
     VFVDLFNLST YLIPRHWIPK MNPTIHKFLY TAEYCDSSYF SSDESD
//
